A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)

Trial Profile

A Multicenter Open-Label Extension Study To Assess Long-Term Safety Of PF-00547659 In Subjects With Ulcerative Colitis (TURANDOT II)

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 28 Aug 2017

At a glance

  • Drugs SHP 647 (Primary)
  • Indications Ulcerative colitis
  • Focus Adverse reactions
  • Acronyms TURANDOT-II
  • Sponsors Pfizer; Shire
  • Most Recent Events

    • 01 Feb 2017 This trial has been completed in Bulgaria as per European Clinical Trials Database record.
    • 26 Dec 2016 This trial has been completed in Bulgaria as per European Clinical Trials Database record.
    • 17 Jun 2016 This trial has been completed in Austria as per European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top